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Summary
Background.  —  Takotsubo  cardiomyopathy  (TTC)  continues  to  be  under-diagnosed,  due  to  itscardiomyopathy;
Pheochromocytoma;
Catecholamines
varying presentation,  with  potentially  serious  consequences  if  treatment  is  delayed.
Aims. —  To  demonstrate  the  consistent  involvement  of  catecholaminergic  stress  in  TTC,  regard-
less of  the  trigger.
Methods.  —  Between  01  July  2009  and  31  August  2013,  patients  managed  in  our  centre  for
thoracic pain  syndrome,  with  or  without  troponin  release,  were  followed  up  prospectively.
Abbreviations: +, 2-mimetic intoxication; CK, creatine kinase; LV, left ventricular; LVEF, left ventricular ejection fraction; PCPG,
pheochromocytoma/paraganglioma; TTC, Takotsubo cardiomyopathy.
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TTC  was  diagnosed  from  the  apical  ballooning  seen  on  left  ventricular  imaging  (angiography  or
transthoracic  echocardiography)  in  the  absence  of  a  signiﬁcant  coronary  artery  lesion.  Triggers
(emotional trauma,  surgical  stress  and  2-mimetic  intoxication)  were  recorded;  catecholamine-
secreting  tumours  were  screened  for  with  a  urinary  methoxylate-derivative  assay.
Results. —  TTC  was  diagnosed  in  40  out  of  2754  (1.5%)  patients  with  thoracic  pain  syndrome,
with or  without  troponin  release.  Triggers  were  emotional  trauma  (n  =  29,  72.5%),  surgical  stress
(n =  5,  12.5%),  adrenergic  intoxication  (n  =  3,  7.5%)  and  catecholaminergic  tumour  (n  =  3,  7.5%).
Mean left  ventricular  ejection  fraction  at  admission  was  38.0  ±  15.7%.  Eight  (20%)  patients
initially showed  cardiogenic  shock.  In-hospital  mortality  was  7.5%,  with  no  deaths  from  car-
diogenic causes.  Thirty-ﬁve  (94.6%)  of  the  survivors  had  recovered  a  normal  left  ventricular
ejection  fraction  (>  55%)  by  discharge.
Conclusion.  —  Whatever  the  trigger,  the  common  denominator  in  TTC  is  catecholaminergic
stress. Classically  suggested  after  emotional  trauma,  TTC  may  also  be  induced  by  surgical  stress
or endogenous  or  iatrogenic  2-mimetic  intoxication.  The  various  contexts  all  have  a  similarly
excellent  cardiovascular  prognosis  if  treated  early.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  La  cardiomyopathie  de  Takotsubo  (CTT)  est  sous-diagnostiquée  ou  tardivement  du
fait des  différents  types  de  présentation  pouvant  conduire  à  des  conséquences  potentiellement
léthales.
Objectif.  —  Mettre  en  évidence  qu’un  stress  catécholaminergique  est  l’unique  voie  phys-
iopathologique  des  CTT.
Méthodes.  —  Les  patients  hospitalisés  en  unité  de  soins  intensifs  pour  douleur  thoracique  avec
ou sans  libération  de  troponine  entre  le  1er juillet  2009  et  le  31  août  2013  ont  été  suivis.  Le  diag-
nostic de  CTT  était  porté  devant  l’aspect  de  ballonisation  apical  (ou  médian/basal)  du  ventricule
gauche en  l’absence  de  lésion  coronaire.  Les  facteurs  déclenchants  étaient  identiﬁés  (stress
psychologique,  contexte  péri-opératoire,  intoxication  bêta-2  mimétique).  La  présence  d’une
tumeur catécholaminergique  était  recherchée  par  dosage  des  dérivés  méthoxylés  urinaires.
Résultats.  — Le  diagnostic  de  CTT  a  été  porté  chez  40  patients  pris  en  charge  pour  douleur
thoracique avec  ou  sans  libération  de  troponine  (40/2754,  1,5  %).  Les  facteurs  déclenchants
retrouvés  étaient  :  stress  psychologique  (n  =  29,  72,5  %)  ;  péri-opératoire  (n  =  5,  12,5  %)  ;  intoxi-
cation bêta-mimétique  (n  =  3,  7,5  %)  ;  et  tumeur  sécrétante  (n  =  3,  7,5  %).  La  fraction  d’éjection
moyenne ventriculaire  gauche  (FEVG)  à  la  prise  en  charge  était  de  38,0  ±  15,7  %.  La  mortalité
intra-hospitalière  était  de  7,5  %.  Trente-cinq  survivants  (94,6  %)  avaient  retrouvé  une  fonction
ventriculaire  normale  à  la  sortie  d’hospitalisation.
Conclusions.  —  Peu  importe  le  mécanisme,  la  décharge  catécholaminergique  est  l’unique  voie
physiopathologique  de  la  CTT.  Le  stress  psychologique  est  la  description  la  plus  classique  mais
il est  primordial  d’évoquer  ce  diagnostic  en  cas  de  dysfonction  ventriculaire  gauche  aiguë  dans
un contexte  péri-opératoire,  d’intoxication  au  beta-mimétique  et  de  rechercher  la  présence
d’une tumeur  sécrétante  de  catécholamines.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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akotsubo  cardiomyopathy  (TTC)  is  a  rare,  but  potentially
evere,  disease  [1,2]  that  was  ﬁrst  deﬁned  in  1990  [3]. Sev-
ral  retrospective  studies  have  estimated  that  0.7—4.9%  of
atients  presenting  with  suspected  acute  coronary  syndrome
ave  TTC  [4],  and  its  incidence  is  estimated  to  be  29.8  per
,000,000  inhabitants  in  a  global  population  [4,5].  Classi-
ally,  diagnosis  is  considered  in  cases  of  emotional  trauma
3].
The  clinical  presentation  of  TTC  may  mimic  acute  coro-
ary  syndrome,  generally  involving  chest  pain,  new  electro-
ardiographical  abnormalities  and  biological  abnormalities
E
r
crelease  of  troponin  and  creatine  kinase  [CK])  [6].  Imag-
ng  (transthoracic  echocardiography,  left  ventricular  [LV]
ngiography  or  cardiac  magnetic  resonance  imaging)  shows
ransient  LV  dysfunction;  the  regional  wall  motion  abnormal-
ties  extend  beyond  a single  epicardial  vascular  distribution
apical  ballooning  with  an  octopus  trap  [Japanese:  takot-
ubo]  pattern).  Coronary  angiography  rules  out  signiﬁcant
oronary  artery  stenosis  [6]  and  normal  LV  systolic  function
s  usually  recovered  within  a  few  weeks  [7,8].The  pathophysiology  of  TTC  remains  controversial.
picardial  coronary  spasm  [9—11], atheromatous  plaque
upture  [12],  myocarditis  [13]  or  infarction  with  healthy
oronaries  [14]  have  been  suggested,  but  are  now  dismissed
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[15].  Catecholaminergic  stress  following  emotional  trauma
is  presently  the  hypothesis  of  choice  [9,16].  However,  the
current  Mayo  Clinic  criteria  [6]  require  catecholamine-
secreting  tumour  to  be  ruled  out  for  a  diagnosis  of  TTC.
The  aim  of  the  present  study  was  to  demonstrate
the  major  involvement  of  catecholaminergic  stress  in  TTC
induced  by  different  triggers.
Methods
Between  01  July  2009  and  31  August  2013,  patients  man-
aged  in  our  centre  for  chest  pain  syndrome  and/or  troponin
release  were  followed  up.  TTC  was  diagnosed  exclu-
sively  from  an  LV  angiographical  or  echocardiographical
pattern  of  apical  (typical  TTC)  or  medial  or  basal  balloon-
ing  [17]  (medial  or  inverse  TTC)  [6]  without  signiﬁcant
coronary  lesions  on  angiography.  Left  ventricular  ejection
fraction  (LVEF)  was  measured  on  LV  angiography  (Axiom
Sensis  XP;  Siemens,  Erlangen,  Germany)  and/or  echocar-
diography  using  the  Simpson  biplane  method  (Vivid  E9;
GE-Vingmed,  Horten,  Norway).  Two  experienced  blinded
operators  analysed  segmental  kinetics  retrospectively  from
DICOM  recordings.
Data  were  collected  on  history,  cardiovascular  risk  fac-
tors  and  context  of  onset  (emotional  trauma,  surgical  stress
or  2-mimetic  intoxication  [+]).
From  01  September  2011,  all  patients  (19/40)  under-
went  complementary  screening  for  catecholamine-secreting
tumour  (pheochromocytoma/paraganglioma  [PCPG])  by
urinary  methoxylate-derivative  high-performance  liquid
chromatography  assay  (Chromsystems  GmbH,  Munich,
Germany)  within  the  ﬁrst  3  days  and  thoracic-abdominal-
pelvic  computed  tomography  or  methoxy-isobutyl-isonitrile
scintigraphy.  Three  measurements  of  24-hour  urinary
methoxylate-derivative  concentrations  were  taken  during
the  ﬁrst  3  consecutive  days  after  admission.
The  characteristics  of  the  overall  population  and  various
groups  were  studied  according  to  trigger  mechanism:  emo-
tional  trauma,  surgical  stress,  PCPG  or  +.  Clinical  follow-up
comprised  functional  and  therapeutic  assessment  at  1,  3  and
12  months.
LVEF  was  assessed  by  echocardiography  and/or  LV  angiog-
raphy  at  initial  assessment,  and  by  echocardiography  at  7
days,  1  month  and  12  months  after  onset.  Troponin  and
CK  concentrations  were  measured  during  the  initial  hospi-
tal  stay  at  several  time  points  after  TTC  onset  (6,  12,  24,
48  and  72  hours).  Only  peak  CK  and  troponin  concentrations
are  presented.
Statistical analysis
Statistical  analysis  was  performed  using  Stata  software,
version  12  (StataCorp,  College  Station,  TX,  US).  The  tests
were  two-sided,  with  a  type  I  error  set  at    =  0.05.  Base-
line  characteristics  are  presented  as  the  mean  ±  standard
deviation  or  median  (interquartile  range)  for  each  group  for
continuous  data  and  as  the  number  of  patients  and  associ-
ated  percentages  for  categorical  variables.  These  variables
were  compared  between  groups  using  the  Chi2 or  Fisher’s
exact  test  for  categorical  variables  and  Student’s  t  test
or  the  Mann—Whitney  test  for  quantitative  variables,  with
p
0
m
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ormality  veriﬁed  by  the  Shapiro—Wilk  test  and  homoscedas-
icity  by  the  Fisher—Snedecor  test.  Owing  to  sample  size,
on-parametric  tests  were  often  preferred.  Considering  the
ample  size  and  univariate  results,  no  multivariable  analysis
as  considered.  Finally,  to  study  the  evolution  of  variables
t  several  time  points,  mixed  models,  taking  into  account
ithin  and  between  subject  variability,  were  considered.
esults
tudy population characteristics
etween  01  July  2009  and  31  August  2013,  2754  patients
ere  admitted  to  our  centre  for  chest  pain,  with  or  without
roponin  release.  A  diagnosis  of  TTC  was  conﬁrmed  in  40
atients  (40/2754,  1.5%;  Fig.  1).  Medical  care  was  initiated
t  a  mean  of  9.8  ±  6.2  hours  after  symptom  onset.
History-taking  found  acute  adrenergic  stress  concomi-
ant  with  symptom  onset:  emotional  trauma  (29/40,  72.5%:
ncluding  family  death  [11/29,  37.9%]  and  physical  aggres-
ion  [3/29,  10.3%]),  surgery  (5/40,  12.5%:  two  ears,  nose
nd  throat/bronchopulmonary  carcinoma  resections,  one
aparoscopic  hernia  operation,  one  carotid  endarterectomy
nd  one  kidney  transplant)  and  adrenergic  intoxication
3/40,  7.5%:  two  overdoses  of  2-mimetics  for  acute
sthma  and  one  voluntary  intoxication  by  intravenous
drenalin  injection).  These  last  three  patients  (adrener-
ic  intoxication)  were  female  (aged  27,  60  and  66  years,
espectively),  with  a  cardiogenic  shock  presentation  for  the
oungest  (voluntary  intoxication  by  intravenous  adrenalin
njection).  Interestingly,  in  three  (7.5%)  patients,  elevated
rinary  methoxylate-derivative  concentrations  enabled  the
iagnosis  of  a  catecholamine-secreting  tumour  (one  para-
anglioma  and  two  pheochromocytomas)  leading  to  TTC,
onﬁrmed  by  thoracic-abdominal-pelvic  computed  tomo-
raphy  or  methoxy-isobutyl-isonitrile  scintigraphy.  These
hree  patients  (two  women  and  one  man,  aged  65,  50
nd  41  years,  respectively)  did  not  exhibit  any  symp-
oms  of  catecholamine-secreting  tumour  (no  hypertension,
eadaches  or  palpitations)  before  the  diagnosis  of  TTC.
Patients  with  TTC  due  to  emotional  trauma  were  older
68.9  ±  11.7  vs  58.5  ±  14.4  years;  P  =  0.05)  and  more  were
emale  (29/29  [100%]  vs  6/11  [54.5%];  P  =  0.001)  compared
ith  patients  in  the  three  other  groups  (surgery,  +  and
CPG).  TTC  characteristics  are  shown  in  Table  1.
Two  cases  were  of  recurrence  (one  emotional  trauma  and
ne  PCPG),  at  intervals  of  3  months  and  4  years,  respec-
ively,  after  complete  recovery.
There  were  immediate  non-speciﬁc  electrocardiograph-
cal  abnormalities  in  27  (67.5%)  patients:  ST-segment  and
-wave  abnormalities  and  presence  of  Q  wave;  the  other  13
atients  had  normal  electrocardiograms.
iological characteristics
e  observed  increased  peak  concentrations  of  CK
nd  troponin  in  all  patients  (40/40).  The  mean  tro-
onin  I  peak  concentration  was  3.89  ±  6.1  g/L  (range
.071—30.5  g/L  [normal  range  0.015—0.045  g/L])  and
ean  CK  peak  concentration  was  687.3  ±  1587.0  g/L
range  96—6461  g/L  [normal  range  39—308  g/L]).
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F on; LV: left ventricle; PCPG: pheochromocytoma/paraganglioma; TTC:
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Figure 2. Urinary metanephrine concentrations.Mean urinary
metanephrine, normetanephrine and total metanephrine concen-
trations were in the normal ranges in emotional trauma, surgery
and -mimetic intoxication situations. However, these three varia-
b
iigure 1. Flowchart of study patients. +: -mimetic intoxicati
akotsubo cardiomyopathy; TTE: transthoracic echocardiography.
Nineteen  patients  had  urinary  methoxylate-derivative
creening.  The  mean  urinary  metanephrine  concentration
as  2.28  ±  8.29  mol/24  hours  (emotional  trauma  0.32
 1.7  mol/24  hours;  surgical  stress  0.65  ±  0.56  mol/24
ours;  +  0.41  ±  0.25  mol/24  hours;  PCPG  15.07  ±  19.8
mol/24  hours)  (normal  range  <  4.4  mol/24  hours).
The  mean  urinary  normetanephrine  concentration  was
.40  ±  3.55  mol/24  hours  (emotional  trauma  1.63  ±  0.8
mol/24  hours;  surgical  stress  2.66  ±  0.73  mol/24  hours;
+  1.62  ±  0.54  mol/24  hours;  PCPG  7.03  ±  8.9  mol/24
ours)  (normal  range  <  2.2  mol/24  hours).
The  mean  total  urinary  metanephrine  concentration  was
.68  ±  11.69  mol/24  hours  (emotional  trauma  1.95  ±
.93  mol/24  hours;  surgical  stress  3.31  ±  1.28  mol/
4  hours;  +  2.04  ±  0.63  mol/24  hours;  PCPG  22.1  ±
8.4  mol/24  hours)  (normal  range  <  5.5  mol/24  hours)
Fig.  2).
The  mean  urinary  concentrations  of  metanephrine,
ormetanephrine  and  total  metanephrine  were  higher  in  the
CPG  group  than  in  the  other  groups  (emotional  trauma,
urgery  and  +)  (P  <  0.05).
maging characteristics
maging  (echocardiography  [35/40,  87.5%]  and/or  LV  angiog-
aphy  [15/40,  37.4%])  was  performed  in  the  cardiological
are  unit  within  3  hours  of  admission  in  all  patients.  Coro-
ary  artery  angiography  (n  =  40,  100%)  found  no  signiﬁcant
esions.
p
t
iles were higher in pheochromocytoma/paraganglioma (PCPG) than
n these other situations and were above the normal ranges.
Evolutions  of  mean  LVEF  are  presented  in  Table  2.  Most
atients  (n  =  35,  80.0%)  presented  with  a  typical  TTC  pat-
ern  (Fig.  3) [6].  The  ﬁve  atypical  forms  (four  medial  and  one
nverse  TTC)  were  all  secondary  to  emotional  trauma.  All  the
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Table  1  Population  characteristics.
All  patients
(n =  40;  100%)
Emotional  trauma
(n =  29;  72.5%)
Surgical  stress
(n =  5;  12.5%)
+  (n  =  3;  7.5%)  PCPG  (n  =  3;  7.5%)
Mean  age  (years)  65.0  ±  13.0  67  ±  11.9  63.5  ±  1.7  51  ±  21  56.5  ±  9.2
Men/women
(n/n)
6/34  0/29  4/1  0/3  2/1
CVRFs
Hypertension  17  (42.5) 14  (48.3) 2  (40.0) 0  1  (33.3)
Smoking  12  (30.0) 8  (27.6) 2  (40.0) 1  (33.3) 1  (33.3)
Diabetes  3  (7.5)  3  (10.3)  0  0  0
Dyslipidaemia  6  (15.0)  5  (17.4)  1  (20.0)  0  0
Familial  history
of  CAD
5  (12.5)  4  (13.8)  0  0  1  (33.3)
Overweight
(BMI  >  25  kg/m2)
8 (20.0)  7  (24.1)  0  1  (33.3)  0
Previous
treatment
Beta-blockers  5  (12.5)  5  (17.5)  0  0  0
CCBs  7  (17.5)  4  (13.8)  2  (40.0)  1  (33.3)  0
ACEIs  3  (7.5)  3  (10.3)  0  0  0
Clinical
presentation
Chest  pain  28  (70.0)  25  (86.2)  0  2  (66.7)  1  (33.3)
APO  4  (10.0)  4  (10.0)  0  0  0
Cardiogenic
shock
8  (20.0)  1  (3.4)  5  (100)  1  (33.3)  1  (33.3)
History  of  TTC  2  (5.0)  1  (3.4)  0  0  1  (33.3)
Forms  of  TTC  (n)
Typical  35  24  5  3  3
Median  4  4  0  0  0
Inverse  1  1  0  0  0
Data are mean ± standard deviation or number (%), unless otherwise indicated. ACEI: angiotensin-converting enzyme inhibitor; APO:
acute pulmonary oedema; +: -mimetic intoxication; BMI: body mass index; CAD: coronary artery disease; CCB: calcium chan-
 mal
I
N
a
l
(nel blockers; CVRF: cardiovascular risk factor; F: female; M:
cardiomyopathy.
perioperative,  +-related  and  PCPG-related  forms  showed  a
typical  TTC  pattern.  There  was  no  difference  in  imaging  TTC
presentation  between  emotional  trauma  patients  and  other
patients  (P  =  0.20);  however,  emotional  trauma  patients  pre-
sented  with  a  higher  initial  LVEF  than  other  patients  (42  ±  14
vs  29  ±  17%;  P  =  0.01).One  emotional  trauma  patient  experienced  recurrence  of
TTC  during  follow-up:  the  primary  episode  was  typical  TTC,
with  complete  recovery  and  the  second  was  inverse  TTC.
e
d
f
Table  2  Left  ventricular  ejection  fraction  follow-up  of  patien
All  patients
(n =  40)
Emotional  traum
(n =  29)
Initial  LVEF  (%)  38.0  ±  15.7  40.1  ±  13.5  
LVEF  at  7  days  (%)  55.9  ±  10.7  53.6  ±  11.1  
LVEF  at  1  month  (%)  57.3  ±  3.7  57.4  ±  4.14  
LVEF  at  1  year  (%)  59.3  ±  3.6  60.2  ±  4.1  
Data are mean ± standard deviation. +: -mimetic intoxication; L
toma/paraganglioma.e; PCPG: pheochromocytoma/paraganglioma; TTC: Takotsubo
n-hospital management
ine  (22.5%)  patients  required  vasopressor  amine  support:
drenaline  (n  =  1,  2.5%);  milrinone  (n  =  1,  2.5%);  noradrena-
ine  (n  =  7),  17.5%;  dobutamine  (n  =  4,  10.0%).  Four  patients
10.0%)  required  mechanically  assisted  circulation  with
xtracorporeal  membrane  oxygenation  for  a  mean  of  3  ±  2
ays.  Invasive  mechanical  ventilation  was  implemented  in
our  patients  (10.0%)  for  a  mean  of  7  ±  2  days.  During
ts  presenting  with  Takotsubo  cardiomyopathy.
a Surgical  stress
(n  =  5)
+ (n  =  3)  PCPG  (n  =  3)
15.0  ±  5  52.0  ±  18.2  29.5  ±  0.7
56.0  ±  1.73  70.3  ±  4.0  55.0  ±  3.5
57.4  ±  2.7  56.0  ±  0.3  55.5  ±  0.7
56.5  ±  2.1  58.3  ±  2.9  61.5  ±  9.2
VEF: left ventricular ejection fraction; PCPG: pheochromocy-
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F  cardiomyopathy. Typical left ventricle apical ballooning with an octopus
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hypothesis  of  catecholaminergic  stress  inducing  acute  LV
dysfunction  [13,18,19],  which  has  been  shown  by  the  present
study  to  be  consistently  involved  in  varying  clinical  situations
(Fig.  4).
Previous  pathophysiological  hypotheses  have  been  ruled
out  by  the  most  recent  ﬁndings.  The  hypothesis  of  myocardi-
tis  was  ruled  out  by  myocardial  biopsy  results  and  was
further  conﬁrmed  by  more  recent  magnetic  resonanceigure 3. Angiographic pattern of left ventricle typical Takotsubo
rap, with left ventricular ejection fraction (EF) of 45%.
he  ﬁrst  48  hours,  angiotensin-converting  enzyme  inhibitors
ere  prescribed  in  23  (57.5%)  cases,  -blockers  in  13  (32.5%)
ases  and  -blockers  in  three  (7.5%)  cases.  The  mean  stay
n  the  cardiological  care  unit  was  7.1  ±  6.7  days.
volution
aemodynamic  evolution  was  favourable  in  all  cases.  LVEF
mproved  as  of  day  7  (Table  2).
However,  three  (7.5%)  patients  in  the  surgical  stress
roup  died  (D8,  D17,  D22)  of  surgery  or  intensive  care
omplications  (nosocomial  infections  for  two  patients
nd  invasive  mechanical  ventilation  complication  for  one
atient)  after  complete  recovery  of  LVEF  (>  55%).  There  was
o  difference  in  terms  of  LVEF  between  emotional  trauma
atients  and  other  patients  at  month  1  (57  ±  4  vs  57  ±  2;
 =  0.62)  and  month  12  (59  ±  8  vs  60  ±  6;  P  =  0.46).
After  a  mean  follow-up  of  23  ±  15  months,  37/40  (92.5%)
atients  were  alive  and  free  of  symptoms,  with  a  mean
VEF  of  59.3  ±  3.6%.  Most  surviving  patients  (n  =  35,  94.6%)
howed  normal  LV  systolic  function  (LVEF  >  55%)  at  discharge;
6  (97.3%)  showed  normal  LV  systolic  function  by  1  month.
iscussionhe  pathophysiology  of  TTC  has  been  controversial  ever
ince  the  disease  was  ﬁrst  described  [10]  but  is  steadily
ecoming  less  so.  Several  authors  have  agreed  on  the
Figure 4. Pathophysiology of Takotsubo cardiomyopathy: from
adrenergic inundation to myocardial stunning. PCPG: pheochromo-
cytoma/paraganglioma.
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imaging  ﬁndings  of  no  signs  of  myocarditis  [20]. The  hypoth-
esis  of  epicardial  coronary  spasm  was  put  forward  [10],  but
ergonovine-induced  spasm  tests  proved  positive  in  only  14%
of  cases  in  the  study  by  Abe  et  al.  [9].  The  hypothesis  of
healthy  coronary  infarction  was  soon  abandoned  [12],  as
evolution  tends  toward  complete  recovery  of  LV  function,
without  myocardial  necrotic  sequelae  on  echocardiography
or  cardiac  magnetic  resonance  imaging.
The  involvement  of  the  adrenergic  cascade  is  presently
the  hypothesis  of  choice  [13]:  physical  or  emotional  stress
inundates  myocardial  -receptors,  stunning  the  left  ventri-
cle.  Blood  catecholamine  concentrations  are  higher  in  TTC
patients  than  in  Killip  class  III  myocardial  infarction  patients
[21].  Anatomopathological  biopsy  ﬁnds  disorganized  cell
architecture  (hypertrophied  myocytes,  intracytoplasmic
areas  ﬁlled  with  glycogen,  reduced  amount  of  contractile
protein  actin)  without  apoptosis  [21].  The  distribution  of
myocardial    receptors  [22]  (a  majority  of  2  receptors  at
the  apex,  with  a  negative  inotropic  effect;  a  majority  of
norepinephrine-sensitive  1  receptors  in  basal  segments,
with  a  positive  inotropic  effect)  suggests  the  consistent
involvement  of  catecholaminergic  stress,  whatever  the  ini-
tial  trigger.
Various  causes  of  endogenous  or  exogenous  stress  (epilep-
tic  seizure  [23],  surgery  [24],  meningeal  haemorrhage
[25,26],  synephrine  dietary  supplements  [27],  hanging  [28]
and  severe  emotional  stress  [6])  or  massive  consumption
of  2-mimetics  saturate  myocardial  2  receptors,  stunning
affected  segments  and  inducing  myocardial  stunning  that  is
relieved  by  clearance  of  the  sympathetic  receptors.  Under-
lying  all  these  situations  is  thus  sudden  major  endogenous
or  exogenous  catecholaminergic  stress  [29].
Studies  are  presently  underway  to  analyse  patients’
genetic  predisposition  to  TTC,  in  terms  of  allele  vari-
ability  and  gene  expression  of  catecholaminergic  pathway
receptors,  regulators  and  transducers  (TAKOGENE  study,
NCT01520610).
Although  presentation  may  be  extremely  serious,
haemodynamic  prognosis  is  favourable  overall  [6]. In  the
present  cohort,  there  were  no  deaths  due  to  LV  systolic
dysfunction  and  LVEF  recovered  completely  (>  55%)  in
94.6%  of  surviving  patients  by  discharge  and  in  97.3%  by  1
month.
Vasopressor  amine  support  in  our  study  was  used  before
TTC  diagnoses  were  made  in  a  cardiogenic  shock  situa-
tion  in  the  majority  of  cases.  After  TTC  diagnoses  were
made,  vasopressor  amine  support  was  stopped,  which  may
explain  the  total  recovery  of  this  population.  Some  of
these  presentations  may  lead  to  misdiagnosis,  especially  in
the  surgical  situation  [30],  where  onset  of  haemodynamic
instability  primarily  suggests  anaphylactic  shock.  Failure
to  obtain  rapid  response  to  vasopressors  is  an  indica-
tion  for  perioperative  echocardiography.  Adrenergic  drugs,
however,  could  aggravate  stunning  if  TTC  has  not  been  diag-
nosed.
Medical  management  of  the  subacute  phase  relies  on  -
receptor  blockers  to  maximize  relief  of  adrenergic  stress  in
the  affected  myocardial  segments,  but  also  on  angiotensin-
converting  enzyme  inhibitors  to  enhance  LV  recovery.  Given
the  risk  of  recurrence,  however  low  (2/40  [5%]  cases  in  the
present  series),  long-course  -blockers  should  be  consid-
ered.
A
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Even  in  cases  of  identiﬁable  exogenous  stress,
atecholamine-secreting  tumour  should  be  screened
or.  Indeed,  pheochromocytoma  and  paraganglioma  have
n  estimated  incidence  of  10  per  million  in  the  general
opulation  [31]. However,  the  present  study  conﬁrmed
hat  the  incidence  is  signiﬁcantly  higher  in  patients  with
TC  (7.5%),  as  described  in  some  case  reports  [32].  In  the
resent  cohort,  a  pheochromocytoma  was  discovered  in  a
atient  presenting  with  TTC  following  emotional  shock  (her
usband’s  funeral).  A  simple  urinary  methoxylate-derivative
ssay  can  detect  most  actively-secreting  catecholaminergic
umours  [33],  as  we  demonstrated  that  the  concentrations
ere  higher  in  such  patients  compared  with  in  other
roups.
tudy limitations
he  limitations  of  the  present  study  should  be  noted.  The
ample  only  comprised  40  patients,  although  the  incidence
as  similar  to  that  in  previous  reports  [6], and  this  was
ne  of  the  largest  prospective  series  published  for  an  entity
hat  is  still  recent.  The  favourable  spontaneous  evolution  of
inor  forms  suggests  that  some  cases  may  be  undiagnosed,
specially  in  perioperative  situations.  Conversely,  over  the
tudy  period,  the  frequent  use  of  the  troponin  assay  and
ystematic  very  early  coronary  artery  and  LV  angiography  in
ase  of  myocardial  infarction  with  non-ST  segment  elevation
orrected  such  underestimation.  We  did  not  perform  any
easurements  of  urinary  metanephrin  and  normetanephrin
oncentrations  in  patients  managed  in  our  intensive  care
nit  for  chest  pain  without  TTC,  although  several  stud-
es  have  evaluated  this  point,  with  several  discrepancies
21,34,35].  Finally,  owing  to  the  sample  size,  a  lack  of  power
ad  to  be  conceded  for  statistical  analysis.
onclusions
he  acute  left  ventricular  systolic  dysfunction  characteriz-
ng  TTC  consistently  involved  myocardial  catecholaminergic
tress,  regardless  of  the  underlying  mechanism.  Although
motional  shock  is  classically  involved,  it  is  essential  to  rule
ut  catecholamine-secreting  tumour  (pheochromocytoma,
araganglioma).  Haemodynamic  instability  in  the  perioper-
tive  period  or  in  patients  treated  with  2-mimetics  may
lso  suggest  TTC.  The  demonstration  of  this  single  patho-
hysiological  mechanism  should  allow  early  diagnosis  and
dapted  treatment,  usually  enabling  complete  recovery  of
V  function.
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